Email Updates
Study
State medical board regulation of compounding in physician offices.
June 9, 2021
Reynolds KA, Hellquist K, Ibrahim SA, et al. Arch Dermatol Res. 2022;314(4):363-367.
Adverse events associated with pharmacy compounding (e.g., parenteral nutrition, sterile compounding) are well-documented. This survey of state medical and osteopathic boards gathered information about compounding-associated adverse events in physician offices and use of compounding standards. Findings indicate that the incidence of in-office compounding-related adverse events is low and that the majority of respondents had not incorporated compounding standards into their regulations.
Related Resources From the Same Author(s)
Related Resources
See More About The Topic
